Difference between revisions of "Part:BBa K1150017"

 
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
−
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K1150017 short</partinfo>
 
<partinfo>BBa_K1150017 short</partinfo>
  
−
..
 
  
−
<!-- Add more about the biology of this part here
+
{| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right"
−
===Usage and Biology===
+
! colspan="2" style="background:#FFBF00;"|pCMV:HA-NLS-dCas9-G9a-NLS:tBGH
 +
|-
 +
|'''Function'''
 +
|DNA binding protein
 +
|-
 +
|'''Use in'''
 +
|Mammalian cells
 +
|-
 +
|'''RFC standard'''
 +
|[https://parts.igem.org/Help:Assembly_standard_25 RFC 25]
 +
|-
 +
|'''Backbone'''
 +
|pSB1C3<br>
 +
|-
 +
|'''Organism'''
 +
|<i>Streptococcus pyogenes</i>
 +
|-
 +
|'''Source'''
 +
|Feng Zhang, Addgene<br>
 +
|-
 +
|'''Submitted by'''
 +
|[http://2013.igem.org/Team:Freiburg Freiburg 2013]
 +
|}
 +
 
 +
 
 +
 
 +
Cas9 is a protein that binds DNA via an protein-RNA-DNA interaction. [https://parts.igem.org/Part:BBa_K1150000 This version of Cas9] (dCas9) is working as a carrier for effectors that want to be brought to DNA in a sequence specific manner. The native nikase activity of the protein has been mutated so that it allows DNA binding without cutting. The sequence is human codon optimized.
 +
The protein is part of team Freiburg's (2013) the [http://2013.igem.org/Team:Freiburg uniCAS toolkit].
 +
 
 +
The usage of the strong [https://parts.igem.org/Part:BBa_K747096 CMV promoter] enables this device to be expressed in a strong manner. If weaker expression levels are needed, we recommend using our [https://parts.igem.org/Part:BBa_K1150018 device with SV40 promoter].
 +
==Usage and Biology==
 +
The dCas9 protein is able to target several loci at once as it interacts with small RNAs to build up a complex that will interact with complementary DNA strands. Its origin is the adaptive immune system of <i>Streptococcus pyogenes </i> called CRISPR. Hijacking this system leads to a whole new approach for multiple gene targeting.
 +
 
 +
The iGEM team Freiburg 2013 combined effectors with this protein to create a toolkit, that is able to activate or repress specific and multiple target loci.
 +
 
 +
This approach offers new possibilities for fundamental epigenetic research, tissue engineering and cancer research.
 +
 
 +
 
  
−
<!-- -->
+
<span class='h3bb'>
−
<span class='h3bb'>Sequence and Features</span>
+
==Sequence and Features==
−
<partinfo>BBa_K1150017 SequenceAndFeatures</partinfo>
+
</span>
 +
<partinfo>BBa_K1150023 SequenceAndFeatures</partinfo>
  
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
 
===Functional Parameters===
 
===Functional Parameters===
−
<partinfo>BBa_K1150017 parameters</partinfo>
+
<partinfo>BBa_K1150023 parameters</partinfo>
 
<!-- -->
 
<!-- -->

Latest revision as of 21:44, 4 October 2013

dCas9 with CMV promoter


pCMV:HA-NLS-dCas9-G9a-NLS:tBGH
Function DNA binding protein
Use in Mammalian cells
RFC standard RFC 25
Backbone pSB1C3
Organism Streptococcus pyogenes
Source Feng Zhang, Addgene
Submitted by [http://2013.igem.org/Team:Freiburg Freiburg 2013]


Cas9 is a protein that binds DNA via an protein-RNA-DNA interaction. This version of Cas9 (dCas9) is working as a carrier for effectors that want to be brought to DNA in a sequence specific manner. The native nikase activity of the protein has been mutated so that it allows DNA binding without cutting. The sequence is human codon optimized. The protein is part of team Freiburg's (2013) the [http://2013.igem.org/Team:Freiburg uniCAS toolkit].

The usage of the strong CMV promoter enables this device to be expressed in a strong manner. If weaker expression levels are needed, we recommend using our device with SV40 promoter.

Usage and Biology

The dCas9 protein is able to target several loci at once as it interacts with small RNAs to build up a complex that will interact with complementary DNA strands. Its origin is the adaptive immune system of Streptococcus pyogenes called CRISPR. Hijacking this system leads to a whole new approach for multiple gene targeting.

The iGEM team Freiburg 2013 combined effectors with this protein to create a toolkit, that is able to activate or repress specific and multiple target loci.

This approach offers new possibilities for fundamental epigenetic research, tissue engineering and cancer research.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 664
    Illegal BglII site found at 5139
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]